You will find below the proxy statement for the Extraordinary General Meeting of Theravance Biopharma, Inc. Shareholders that will be held on September 18, 2026, at 1:30 p.m. Pacific Time. After reviewing these materials, if you were a registered holder of shares of Theravance Biopharma, Inc. on the Record Date, you may vote your shares via the internet at http://www.investorvote.com/TBPH or by telephone by calling 1-800-652-8683 prior to by 11:59 PM, Pacific Time, on September 17, 2026. In order to vote, you will need to have in-hand information from the proxy card mailed to you with the proxy statement on or around August 21, 2026. If you are a beneficial holder of shares of Theravance Biopharma, Inc. (for example, your shares are held in an account at an institution such as a brokerage firm, bank, dealer, or other similar organization), please follow the voting instructions provided by your institution. If you are a beneficial holder, your shares will not be voted by your institution without direction from you pursuant your institution's instructions.